A PYMNTS Company

FTC ends eight-month investigation into Express Scripts-Medco merger

By  |  April 2, 2012

The Federal Trade Commission has closed its eight-month investigation of Medco by Express Scripts. The FTC found that “the merging parties are not particularly close competitors, the market today is not conducive to coordinated interaction, and there is little risk fo the merged company exercising monopsony power.” The vote to close the investigation was 3-1. Commissioner Julie Brill was the lone dissenter, as she described the deal as “a merger to duopoly.”

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Full content: FTC Press Release

     

    Related content: New Horizontal Merger Guidelines Indicate Greater Scrutiny of High Tech and Pharmaceutical Transactions (Janet McDavid & Eric Stock, Hogan Lovells)